A detailed history of Ifrah Financial Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ifrah Financial Services, Inc. holds 3,337 shares of LLY stock, worth $2.6 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
3,337
Previous 3,437 2.91%
Holding current value
$2.6 Million
Previous $3.11 Million 4.98%
% of portfolio
0.81%
Previous 0.89%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$772.14 - $960.02 $77,214 - $96,002
-100 Reduced 2.91%
3,337 $2.96 Million
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $366,059 - $459,065
-505 Reduced 12.81%
3,437 $3.11 Million
Q1 2024

May 06, 2024

SELL
$592.2 - $792.28 $128,507 - $171,924
-217 Reduced 5.22%
3,942 $3.07 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $553,025 - $651,943
-1,053 Reduced 20.2%
4,159 $2.42 Million
Q3 2023

Nov 06, 2023

SELL
$434.7 - $599.3 $48,686 - $67,121
-112 Reduced 2.1%
5,212 $2.8 Million
Q2 2023

Aug 01, 2023

SELL
$350.74 - $468.98 $31,566 - $42,208
-90 Reduced 1.66%
5,324 $2.5 Million
Q1 2023

May 04, 2023

SELL
$310.63 - $364.82 $38,828 - $45,602
-125 Reduced 2.26%
5,414 $1.86 Million
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $46,624 - $54,327
-145 Reduced 2.55%
5,539 $2.03 Million
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $149,722 - $170,624
505 Added 9.75%
5,684 $1.84 Million
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $35,398 - $41,563
-127 Reduced 2.39%
5,179 $1.68 Million
Q1 2022

May 03, 2022

BUY
$234.69 - $291.66 $3,989 - $4,958
17 Added 0.32%
5,306 $1.52 Million
Q4 2021

Feb 01, 2022

SELL
$224.85 - $279.04 $1,124 - $1,395
-5 Reduced 0.09%
5,289 $1.46 Million
Q3 2021

Nov 01, 2021

SELL
$221.6 - $272.71 $5,318 - $6,545
-24 Reduced 0.45%
5,294 $1.22 Million
Q2 2021

Aug 05, 2021

SELL
$180.55 - $233.54 $722 - $934
-4 Reduced 0.08%
5,318 $1.22 Million
Q1 2021

Apr 30, 2021

SELL
$164.32 - $212.72 $38,286 - $49,563
-233 Reduced 4.19%
5,322 $994,000
Q4 2020

Feb 05, 2021

SELL
$130.46 - $172.63 $374,028 - $494,930
-2,867 Reduced 34.04%
5,555 $938,000
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $15,645 - $18,096
-107 Reduced 1.25%
8,422 $1.25 Million
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $34,923 - $42,030
-256 Reduced 2.91%
8,529 $1.4 Million
Q1 2020

May 07, 2020

BUY
$119.05 - $147.35 $155,003 - $191,849
1,302 Added 17.4%
8,785 $1.22 Million
Q4 2019

Feb 06, 2020

SELL
$106.92 - $132.43 $10,157 - $12,580
-95 Reduced 1.25%
7,483 $984,000
Q3 2019

Nov 04, 2019

SELL
$106.79 - $116.16 $19,649 - $21,373
-184 Reduced 2.37%
7,578 $847,000
Q2 2019

Aug 06, 2019

SELL
$110.79 - $129.32 $10,414 - $12,156
-94 Reduced 1.2%
7,762 $860,000
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $10,240 - $12,053
-92 Reduced 1.16%
7,856 $1.02 Million
Q4 2018

May 13, 2019

SELL
$105.9 - $118.64 $6,671 - $7,474
-63 Reduced 0.79%
7,948 $920,000
Q3 2018

Nov 05, 2018

SELL
$85.86 - $107.31 $15,283 - $19,101
-178 Reduced 2.17%
8,011 $860,000
Q2 2018

Aug 01, 2018

BUY
$75.7 - $86.88 $2,043 - $2,345
27 Added 0.33%
8,189 $699,000
Q1 2018

May 03, 2018

BUY
$74.21 - $87.6 $50,611 - $59,743
682 Added 9.12%
8,162 $632,000
Q4 2017

Feb 01, 2018

BUY
$81.94 - $87.89 $612,911 - $657,417
7,480
7,480 $632,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ifrah Financial Services, Inc. Portfolio

Follow Ifrah Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifrah Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ifrah Financial Services, Inc. with notifications on news.